Survivin as a Multifaceted Oncogenic Driver and Therapeutic Target in Renal Cell Carcinoma
Shawna Tuli, Gabrielle Inserra, Yaeko Murakami, Cais Vo, Sarvesh Senguttavan, Yongho Bae, David M. Gau
This study identifies survivin as a key oncogenic driver in renal cell carcinoma, showing its roles in cell cycle, migration, and mitochondrial function, and suggests it as a therapeutic target.
Disease Models & Mechanisms · Aug 1, 2026Peer-reviewedCancer Biology